REQUEST A DEMO
Total
USD $0.00
Search more companies

Maksun Biotech Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Maksun Biotech Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Maksun Biotech Private Limited is an enterprise in India, with the main office in Panchkula. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on September 19, 2013. In its most recent financial highlights, the company reported a net sales revenue increase of 19.04% in 2025. Its’ total assets recorded a growth of 15.9%. In, 2025, the company’s net profit margin decreased by 0.16%.

Legal Address
2280 Sector 15
Panchkula; Haryana; Postal Code: 134113

Contact Details: Purchase the Maksun Biotech Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Maksun Biotech Private Limited report to view the information.
Financial Auditors:
Purchase the Maksun Biotech Private Limited report to view the information.
Incorporation Date:
September 19, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Maksun Biotech Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.04%
Total Operating Revenue
19.1%
Operating Profit
34.91%
EBITDA
40.96%
Net Profit/Loss for the Period
13.93%
Total Assets
15.9%
Total Equity
26.4%
Operating Profit Margin
0.83%
Net Profit Margin
-0.16%
Return on Equity (ROE)
-2.28%
Debt / Equity
-32%
Quick Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?